| Analysis | Metabolite Name | Measured Value | Units | Gender | OSA | Sampling | PCOS | CPAP |
|---|---|---|---|---|---|---|---|---|
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 16086 | Counts | Female | Positive | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 21753 | Counts | Female | Negative | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 23853 | Counts | Male | Positive | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 27019 | Counts | Male | Positive | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 32744 | Counts | Female | Negative | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 35693 | Counts | Female | Positive | Morning fasting | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 40528 | Counts | Female | Negative | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 40808 | Counts | Female | Positive | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 42569 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 43005 | Counts | Female | Negative | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 44704 | Counts | Male | Positive | Morning fasting | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 46988 | Counts | Male | Positive | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 47672 | Counts | Female | Negative | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 52357 | Counts | Male | Positive | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 52486 | Counts | Female | Negative | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 52524 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 54583 | Counts | Female | Negative | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 57885 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 62741 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 63450 | Counts | Female | Negative | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 68405 | Counts | Female | Positive | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 69319 | Counts | Female | Negative | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 69528 | Counts | Male | Positive | Morning fasting | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 70455 | Counts | Male | Positive | After SWS onset | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 71117 | Counts | Female | Positive | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 72079 | Counts | Female | Positive | After SWS onset | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 72621 | Counts | Female | Negative | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 76742 | Counts | Female | Positive | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 79428 | Counts | Male | Negative | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 80014 | Counts | Female | Positive | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 80122 | Counts | Male | Positive | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 80305 | Counts | Male | Positive | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 81082 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 92975 | Counts | Female | Positive | After SWS onset | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 94268 | Counts | Female | Positive | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 97833 | Counts | Male | Negative | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 102939 | Counts | Female | Positive | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 104788 | Counts | Female | Negative | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 108866 | Counts | Female | Positive | Morning fasting | PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 113466 | Counts | Female | Negative | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 114668 | Counts | Female | Positive | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 116701 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 123226 | Counts | Female | Positive | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 126327 | Counts | Male | Positive | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 126746 | Counts | Male | Positive | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 132498 | Counts | Female | Positive | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 137664 | Counts | Male | Positive | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 139112 | Counts | Male | Positive | Morning fasting | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 141560 | Counts | Male | Negative | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 144500 | Counts | Female | Positive | After SWS onset | PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 147621 | Counts | Female | Negative | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 147877 | Counts | Male | Positive | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 148558 | Counts | Male | Negative | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 151219 | Counts | Male | Positive | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 152269 | Counts | Female | Negative | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 153400 | Counts | Female | Negative | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 159945 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 175076 | Counts | Female | Negative | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 195872 | Counts | Male | Positive | Morning fasting | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 200673 | Counts | Male | Negative | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 250400 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 275216 | Counts | Female | Positive | After SWS onset | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 306827 | Counts | Male | Positive | Morning fasting | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 326103 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 347747 | Counts | Female | Positive | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 350448 | Counts | Male | Positive | After SWS onset | No PCOS | After CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 365484 | Counts | Female | Negative | Morning fasting | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 383686 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 432169 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 439593 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 529920 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 566377 | Counts | Male | Negative | After SWS onset | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 683265 | Counts | Female | Negative | After SWS onset | PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | 702427 | Counts | Female | Negative | Morning fasting | No PCOS | No CPAP |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Female | Negative | After SWS onset | No PCOS | No CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Female | Negative | After SWS onset | PCOS | No CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Female | Negative | Morning fasting | No PCOS | No CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Female | Negative | Morning fasting | PCOS | No CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Female | Positive | After SWS onset | No PCOS | After CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Female | Positive | After SWS onset | PCOS | No CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Female | Positive | Morning fasting | No PCOS | After CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Female | Positive | Morning fasting | No PCOS | No CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Male | Negative | Morning fasting | No PCOS | No CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Male | Positive | After SWS onset | No PCOS | After CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Male | Positive | After SWS onset | No PCOS | No CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Male | Positive | Morning fasting | No PCOS | After CPAP | |
| MS Q-TOF 6530 positive ion mode | DIPALMITOYLGLYCEROL (*) | Counts | Male | Positive | Morning fasting | No PCOS | No CPAP |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|